SIGA Technologies names two new board members

SIGA Technologies, Inc., which specializes in developing pharmaceutical agents that will combat biowarfare pathogens, has announced the appointment of two new board members, William C. Bevins and Frances Fragos Townsend.

SIGA Technologies applies viral and bacterial genomics combined with computational modeling to design and develop novel products that prevent and treat serious infectious disease, especially disease that can occur as a result of biological warfare. The two new board members have experience in building up the corporate side of the company to help it grow into a commercial-stage company.

Bevins is the president and chief executive officer of Panavision, Inc., and the senior executive vice president of MacAndrews & Forbes Holdings, Inc. He has previously been president and chief executive officer of Andrews Group Incorporated and its subsidiaries, of Marvel Entertainment Group, Inc., and of New Work Communications Group Incorporated.

Townsend is the senior vice president of worldwide government, legal and business affairs at MacAndrews & Forbes Holdings, Inc. She was assistant to President George W. Bush for Homeland Security and Counterterrorism and she has been a counterterrorism, national and homeland security expert for CNN.

"The experiences that Bill and Fran bring to the board will be tremendous assets in driving our near- and long-term objectives,” Dr. Eric Rose, SIGA’s chairman and chief executive officer, said. “Bill's business and leadership skills will be valuable in guiding our corporate development and our continuing drive to become a commercial-stage company. And Fran's extensive leadership experience within government will provide us with unique insights as we continue to develop and commercialize medical countermeasures to bioterrorism. We are fortunate to have such distinguished board members and look forward to their input."